Functional loss of PTEN (which is the negative regulator of PI3K) is thought to occur in up to half of all prostate cancers, and is associated with increased activation of AKT and the downstream kinase mTOR, which is involved in regulating protein synthesis. The gene discussed is AKT1; the disease is Familial prostate cancer.